T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Becton Dickinson
BDX
|
+$3.46B |
| 2 |
UnitedHealth
UNH
|
+$2.79B |
| 3 |
Salesforce
CRM
|
+$2.38B |
| 4 |
Sherwin-Williams
SHW
|
+$1.41B |
| 5 |
Philip Morris
PM
|
+$1.34B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$4.44B |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$2.97B |
| 3 |
GE Aerospace
GE
|
+$2.3B |
| 4 |
HCA Healthcare
HCA
|
+$2.17B |
| 5 |
American International
AIG
|
+$1.68B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.68% |
| 2 | Healthcare | 19.49% |
| 3 | Consumer Discretionary | 13.07% |
| 4 | Financials | 11.18% |
| 5 | Communication Services | 8.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
626
Douglas Emmett
DEI
$1.61B
| $111M | 0.01% |
4,969,556
-120,482
| -2% | -$3.36M |
|
627
Simply Good Foods
SMPL
$861M
| $111M | 0.01% |
2,938,896
+71,355
| +2% | +$2.83M |
|
628
National Bank Holdings
NBHC
$1.78B
| $110M | 0.01% |
2,886,257
+75,293
| +3% | +$2.93M |
|
629
Radian Group
RDN
$4.35B
| $110M | 0.01% |
5,593,253
-68,781
| -1% | -$1.45M |
|
|
NIMC
630
DELISTED
NiSource Inc. Series A Corporate Units
NIMC
| $110M | 0.01% |
967,385
-15,618
| -2% | -$1.81M |
|
631
KT
KT
$9.16B
| $109M | 0.01% |
7,813,134
-84,727
| -1% | -$1.22M |
|
632
Howmet Aerospace
HWM
$91.5B
| $109M | 0.01% |
3,464,589
+200,175
| +6% | +$6.86M |
|
633
Houlihan Lokey
HLI
$8.94B
| $109M | 0.01% |
1,380,194
-18,223
| -1% | -$1.52M |
|
634
Fox Class B
FOX
$24B
| $109M | 0.01% |
3,663,828
-583,947
| -14% | -$19M |
|
635
BJs Wholesale Club
BJ
$12.1B
| $108M | 0.01% |
1,735,575
-3,964
| -0.2% | -$249K |
|
636
Weibo
WB
$1.6B
| $108M | 0.01% |
4,656,428
+466,922
| +11% | +$10.5M |
|
637
CTS Corp
CTS
$1.7B
| $107M | 0.01% |
3,150,545
+59,524
| +2% | +$2.16M |
|
638
Pool Corp
POOL
$5.92B
| $107M | 0.01% |
304,921
+5,369
| +2% | +$2.13M |
|
639
Intellia Therapeutics
NTLA
$1.64B
| $106M | 0.01% |
2,047,331
-172,540
| -8% | -$8.76M |
|
640
Credicorp
BAP
$30.7B
| $106M | 0.01% |
880,892
+48,708
| +6% | +$6.69M |
|
641
Jackson Financial
JXN
$9.03B
| $105M | 0.01% |
3,939,256
+1,088,980
| +38% | +$39.7M |
|
642
DraftKings
DKNG
$10.7B
| $105M | 0.01% |
9,004,185
-61,712
| -0.7% | -$869K |
|
|
JBGS
643
JBG SMITH
JBGS
$597M
| $105M | 0.01% |
4,444,265
-405,320
| -8% | -$10.5M |
|
644
NorthWestern Energy
NWE
$4.16B
| $105M | 0.01% |
1,774,963
-277,317
| -14% | -$16.5M |
|
645
Nu Holdings
NU
$60.1B
| $104M | 0.01% |
27,819,074
+21,442,106
| +336% | +$109M |
|
|
HTO
646
H2O America
HTO
$2.56B
| $104M | 0.01% |
1,666,038
+17,347
| +1% | +$1.07M |
|
647
Grupo Aeroportuario del Sureste
ASR
$7.33B
| $104M | 0.01% |
527,644
-738,795
| -58% | -$156M |
|
|
TCN
648
DELISTED
Tricon Residential Inc.
TCN
| $103M | 0.01% |
10,179,634
+3,483,476
| +52% | +$44.7M |
|
649
Palomar
PLMR
$3.23B
| $103M | 0.01% |
1,600,319
+6,497
| +0.4% | +$392K |
|
650
Kymera Therapeutics
KYMR
$9.35B
| $103M | 0.01% |
5,224,686
+1,329,481
| +34% | +$31.1M |
|
Similar funds
T. Rowe Price Associates's Q2 2022 Portfolio in Review
As of Q2 2022, T. Rowe Price Associates held 3,063 positions worth $791B, down 20% from $992B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
T. Rowe Price Associates's Q2 2022 filing shows 88 new, 1,490 increased, 1,207 reduced and 101 closed positions. Its largest new stake was ESAB: 6,073,363 shares worth $266M. The largest sale was Meta Platforms (Facebook), an estimated $4.44B.
By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q2 2022 buy was ESAB: 6,073,363 shares worth $266M.
- T. Rowe Price Associates added most to Becton Dickinson in Q2 2022, an estimated $3.46B increase.
- T. Rowe Price Associates's biggest Q2 2022 reduction was Meta Platforms (Facebook), cutting an estimated $4.44B.
- T. Rowe Price Associates fully exited Ortho Clinical Diagnostics Holdings plc Ordinary Shares in Q2 2022, selling an estimated $364M.
- T. Rowe Price Associates's ten largest holdings make up 26% of its $791B portfolio in Q2 2022.
- T. Rowe Price Associates opened 88 new positions and closed 101 in Q2 2022.
- T. Rowe Price Associates's portfolio value fell 20% quarter-over-quarter to $791B.
Based on T. Rowe Price Associates's 13F filing for Q2 2022, filed 15 Aug 2022.